Cost-effectiveness of oral versus intravenous antibiotics (OVIVA) in patients with bone and joint infection: evidence from a non-inferiority trial [version 4; peer review: 2 approv...

Por Nicola McMeekin, Claudia Geue, Andrew Briggs, Ines Rombach, Ho Kwong Li, Philip Bejon, Martin McNally, Bridget L. Atkins, Jamie Ferguson, Matthew Scarborough, OVIVA collaborators
Publicado em 2020-01-01